Abstract
Background: The aim of this phase II study was to assess the activity of panitumumab in combination with oxaliplatin, 5-fluorouracil, and external radiotherapy (RT) as preoperative treatment in locally advanced rectal cancer patients. Patients and methods: Patients had rectal adenocarcinoma, cT3N+ or cT4N2/+ stage, located
Original language | English |
---|---|
Pages (from-to) | 2424-2430 |
Number of pages | 7 |
Journal | Annals of Oncology |
Volume | 22 |
Issue number | 11 |
DOIs | |
Publication status | Published - Nov 2011 |
Keywords
- 5-fluorouracil
- Chemoradiotherapy
- Oxaliplatin
- Panitumumab
- Radiotherapy
- Rectal cancer
ASJC Scopus subject areas
- Oncology
- Hematology